VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CLVT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CLVTClarivate Plc
$2.44$1.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

CLVT logoClarivate Plc(CLVT)Earnings, Financials & Key Ratios

CLVT•NYSE
$2.22
Price updated Jul 2, 2026
SectorTechnologyIndustryIT ServicesSub-IndustryVertical Software and Industry Platforms
AboutClarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.Show more
  • Revenue$2.46B-4.0%
  • EBITDA$829M+83.6%
  • Net Income-$201M+68.4%
  • EPS (Diluted)-0.30+68.7%
  • Gross Margin66.05%
  • EBITDA Margin33.75%+91.2%
  • Operating Margin2.91%+127.0%
  • Net Margin-8.19%+67.1%
  • ROE-4.03%+64.8%

CLVT Price & Volume

Clarivate Plc (CLVT) stock price & volume — 10-year historical chart

Loading chart...

Persistent Revenue Contraction Challenges Conglomerate Value Proposition

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Strained
Cash Flow:Mixed
Primary Risk:High leverage and goodwill

Key Thesis Takeaways

  • Clarivate faces a challenging fundamental outlook characterized by persistent organic revenue contraction, as evidenced by the 1.4% year-over-year decline in 2026Q1 revenue.
  • While the company maintains a stable 67.2% gross margin, the inability to translate this into consistent GAAP profitability—highlighted by a -6.9% net margin in the most recent quarter—raises significant concerns regarding the efficacy of its cross-selling strategy.
  • Investors should remain cautious given the elevated 0.91 debt-to-equity ratio and the potential for further goodwill impairment risks associated with its $1.6 billion goodwill balance.

Verdict Logic

the company's inability to achieve consistent GAAP profitability, combined with a 0.84 current ratio and a $7.6 billion accumulated deficit in retained earnings, suggests significant long-term solvency risks.

CLVT Growth Metrics

Clarivate Plc (CLVT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years14.38%
3 Years-2.63%
TTM-3.25%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM79.36%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM78.35%

Return on Capital

10 Years-5.01%
5 Years-6.86%
3 Years-2.71%
Last Year0.73%

CLVT Recent Earnings

Clarivate Plc (CLVT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
Apr 29, 2026
Metric
Actual
Est
EPS
$0.18+28.6%
$0.14
Rev
$586M+2.8%
$569M
Q1 2026
Feb 24, 2026
Metric
Actual
Est
EPS
$0.20+25.0%
$0.16
Rev
$617M+2.0%
$605M
Q4 2025
Oct 29, 2025
Metric
Actual
Est
EPS
$0.18+12.5%
$0.16
Rev
$623M+3.0%
$605M
Q3 2025
Jul 30, 2025
Metric
Actual
Est
EPS
$0.18+0.0%
$0.18
Rev
$621M+8.9%
$570M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 29, 2026
$0.18vs $0.14+28.6%
$586Mvs $569M+2.8%
Q1 2026Feb 24, 2026
$0.20vs $0.16+25.0%
$617Mvs $605M+2.0%
Q4 2025Oct 29, 2025
$0.18vs $0.16+12.5%
$623Mvs $605M+3.0%
Q3 2025Jul 30, 2025
$0.18vs $0.18+0.0%
$621Mvs $570M+8.9%
Based on last 12 quarters of dataView full earnings history →

Latest CLVT News

Recent stock market news and headlines for Clarivate Plc (CLVT)

PRNewsWire·Jun 23, 2026
Clarivate Releases 2025 Sustainability Report

New report highlights progress against goals and a decline in total carbon emissions LONDON, June 23, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released its 2025 Sustainability Report, highlighting continued progress against its sustainability goals, including reduction of total reported greenhouse gas emissions by 24%. Clarivate partners with 45,000 organizations worldwide, including universities, research institutions, corporations, law firms, government agencies and life science and healthcare companies to address global challenges.

GuruFocus·Jun 17, 2026
Clarivate Releases Journal Citation Reports 2026

Clarivate Releases Journal Citation Reports 2026 PR Newswire LONDON, June 17, 2026

PRNewsWire·Jun 17, 2026
Clarivate Releases Journal Citation Reports 2026

Advancing transparency and responsible journal evaluation LONDON, June 17, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the release of the Journal Citation Reports 2026. Now in its sixth decade, Journal Citation Reports (JCR) continues to provide a publisher-neutral framework for assessing journal influence across the global research ecosystem.

Peers Comparison

Key metrics vs top competitors for Clarivate Plc (CLVT)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CLVT logoCLVTClarivate PlcCurrent
$2.22$1.42B-7.40-3.97%-8.19%-4.03%—
VRSK logoVRSKVerisk Analytics, Inc.
$183.72$24.07B28.316.63%29.34%——
MSCI logoMSCIMSCI Inc.
$582.03$42.37B37.419.74%40.74%——
TRI logoTRIThomson Reuters Corporation
$84.91$37.07B24.973%19.93%12.68%—
IHS logoIHSIHS Holding Limited
$8.20$2.75B19.52-7.55%11.96%——
SPGI logoSPGIS&P Global Inc.
$414.97$122.83B28.317.94%30.37%12.92%—

Compare CLVT vs Peers

Clarivate Plc (CLVT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs VRSK

Most directly comparable listed peer for CLVT.

Scale Benchmark

vs GOOGL

Larger-name benchmark to compare CLVT against a more recognizable public peer.

Peer Set

Compare Top 5

vs VRSK, MSCI, TRI, IHS

CLVT SEC Filings & Documents

Clarivate Plc (CLVT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 29, 2026·SEC

Material company update

Mar 26, 2026·SEC

Material company update

Feb 24, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 19, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 29, 2026·SEC

FY 2025

Oct 29, 2025·SEC

FY 2025

Jul 30, 2025·SEC

Get notified when CLVT posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CLVT Frequently Asked Questions

Clarivate Plc (CLVT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Clarivate Plc's revenue?

Clarivate Plc (CLVT) reported $2.45B in revenue for fiscal year 2025. This represents a 167% increase from $917.6M in 2017.

How fast is Clarivate Plc growing?

Clarivate Plc (CLVT) saw revenue decline by 4.0% over the past year.

Is CLVT profitable?

Clarivate Plc (CLVT) reported a net loss of $137.4M for fiscal year 2025.

Dividend & Returns
What is CLVT's return on equity?

Clarivate Plc (CLVT) has a return on equity (ROE) of -4.0%. Negative ROE indicates the company is unprofitable.

What is Clarivate Plc's free cash flow?

Clarivate Plc (CLVT) generated $597.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in CLVT back in 2017?

Total return calculator · dividends reinvested · 9+ years of data

See returns →